Mori M - Search Results

1

Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.

Zhang Z, Garzotto M, Davis EW 2nd, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE, Dashwood RH, Hendrix DA, Ho E, Shannon J. Zhang Z, et al. Among authors: mori m. Nutr Cancer. 2020;72(1):74-87. doi: 10.1080/01635581.2019.1619783. Epub 2019 Jun 1. Nutr Cancer. 2020. PMID: 31155953 Free PMC article. Clinical Trial.

2

Agent Orange as a risk factor for high-grade prostate cancer.

Ansbaugh N, Shannon J, Mori M, Farris PE, Garzotto M. Ansbaugh N, et al. Among authors: mori m. Cancer. 2013 Jul 1;119(13):2399-404. doi: 10.1002/cncr.27941. Epub 2013 May 13. Cancer. 2013. PMID: 23670242 Free PMC article.

3

Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy.

Atwell LL, Zhang Z, Mori M, Farris P, Vetto JT, Naik AM, Oh KY, Thuillier P, Ho E, Shannon J. Atwell LL, et al. Among authors: mori m. Cancer Prev Res (Phila). 2015 Dec;8(12):1184-1191. doi: 10.1158/1940-6207.CAPR-15-0119. Epub 2015 Oct 28. Cancer Prev Res (Phila). 2015. PMID: 26511489 Free PMC article. Clinical Trial.

4

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial.

Zhang Z, Garzotto M, Beer TM, Thuillier P, Lieberman S, Mori M, Stoller WA, Farris PE, Shannon J. Zhang Z, et al. Among authors: mori m. Nutr Cancer. 2016 Nov-Dec;68(8):1309-1319. doi: 10.1080/01635581.2016.1224365. Epub 2016 Sep 20. Nutr Cancer. 2016. PMID: 27646578 Free PMC article. Clinical Trial.

5

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma.

Beer TM, Eilers KM, Garzotto M, Hsieh YC, Mori M. Beer TM, et al. Among authors: mori m. Cancer. 2004 Feb 15;100(4):758-63. doi: 10.1002/cncr.20024. Cancer. 2004. PMID: 14770432 Free article. Clinical Trial.

6

Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies.

Garzotto M, Park Y, Mongoue-Tchokote S, Bledsoe J, Peters L, Blank BH, Austin D, Beer TM, Mori M. Garzotto M, et al. Among authors: mori m. Cancer. 2005 Nov 1;104(9):1911-7. doi: 10.1002/cncr.21420. Cancer. 2005. PMID: 16130139 Free article.

7

Effect of calcitriol on prostate-specific antigen in vitro and in humans.

Beer TM, Garzotto M, Park B, Mori M, Myrthue A, Janeba N, Sauer D, Eilers K. Beer TM, et al. Among authors: mori m. Clin Cancer Res. 2006 May 1;12(9):2812-6. doi: 10.1158/1078-0432.CCR-05-2310. Clin Cancer Res. 2006. PMID: 16675575

8

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.

Garzotto M, Hudson RG, Peters L, Hsieh YC, Barrera E, Mori M, Beer TM, Klein T. Garzotto M, et al. Among authors: mori m. Cancer. 2003 Oct 1;98(7):1417-22. doi: 10.1002/cncr.11668. Cancer. 2003. PMID: 14508828 Free article.

9

Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy.

Spurgeon SE, Hsieh YC, Rivadinera A, Beer TM, Mori M, Garzotto M. Spurgeon SE, et al. Among authors: mori m. J Urol. 2006 Mar;175(3 Pt 1):918-22. doi: 10.1016/S0022-5347(05)00353-8. J Urol. 2006. PMID: 16469580

10

Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigen.

Panagiotou I, Beer TM, Hsieh YC, Mori M, Peters L, Klein T, Garzotto M. Panagiotou I, et al. Among authors: mori m. Oncology. 2004;67(3-4):194-202. doi: 10.1159/000081317. Oncology. 2004. PMID: 15557778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,992 results

Search Page

Filters